
ARN Announces Michael Cooper as Chief Executive Officer
We are pleased to announce we have appointed Michael Cooper as American Rheumatology Network’s (ARN) new CEO, effective immediately. Michael’s appointment reflects ARN’s current state:
We are pleased to announce we have appointed Michael Cooper as American Rheumatology Network’s (ARN) new CEO, effective immediately. Michael’s appointment reflects ARN’s current state:
To Our Members and Partners, American Rheumatology Network (ARN) and Articularis Healthcare Group Inc., (AHG) stands with the rheumatology community, with the Coalition of State
Each patient is unique. What if their treatment path was too? That possibility is at the core of precision medicine. J. Eugene Huffstutter, MD Precision
Trio Health, a leading technology provider of real-world data and insights on patients announces the launch of the first-ever Patient Voice database in Rheumatology to acknowledge and incorporate the voice of the patient in access programs, clinical development, and brand team care management programs.
The ARN-Trio registry recently hosted a webinar unlocking deep insights into the “Why” behind patients discontinuing prescription therapy. The recorded webinar is available here. ARN-Trio
Analysis of the American Rheumatology Network-Trio Health (ARN-Trio) registry finds a surge in new prescriptions for Merck’s Renflexis infliximab biosimilar. The ARN-Trio registry is the
We are excited to announce that we are providing all American Rheumatology Network (ARN) physicians with a group membership in the American Medical Association (AMA),
Analysis of the American Rheumatology Network-Trio Health (ARN-Trio) registry finds that AbbVie’s Rinvoq use is increasing rapidly as a proportion of JAK inhibitor use. Rheumatologists
American Rheumatology Network (ARN) and Trio Health (Trio) have launched the first rheumatology registry that combines pharmacy dispensing data with electronic medical records (EMR) to
The American Rheumatology Network (ARN) has been so successful with cost management, particularly via the use of biosimilars, that it believes its model is worthy
by Colin Edgerton We are seeing COVID-19 cases peak in many areas of the US, prompting thoughts about what comes next for rheumatology practices. Many
As of 12:30pm ET on March 17, 2020 CMS has sent out an official notification stating that effective for services starting March 6, 2020 (retroactive),
The American Rheumatology Network (ARN) continues to monitor federal, state and local health advisories regarding the coronavirus (COVID-19) and will update this resource accordingly. Please
Updated March 17, 2020 3:00pm American Rheumatology Network (ARN) members are concerned about safe access to care during the COVID-19 pandemic. The Centers for Disease
Originally published in The Rheumatologist The Centers for Medicare & Medicaid Services (CMS) Physician Fee Schedule final rule for 2020 includes a big win for
American Rheumatology Network
2001 2nd Ave.
Suite 202
Summerville, SC 29486
P: 843-329-8831
F: 843-793-6186
E: info@arngpo.com